Ars Pharmaceuticals Inc share price logo

Ars Pharmaceuticals Inc Share Price

NASDAQ: SPRY

Small Cap

$8.32

-0.57

(-6.41%)

as on

Ars Pharmaceuticals Inc Stock Performance

as on March 19, 2026 at 6:59 am IST

  • Day's High

    $8.32
    $8.93

    7.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.66
    $18.90
    downward going graph

    19.95%

    Downside

    127.16%

    Upside

    downward going graph

Ars Pharmaceuticals Inc share price movements today

Previous Close
$8.89
Open
$8.85
Volume
1.4M
Day's Low - High
$8.32 - $8.93
52 Week Low - High
$6.66 - $18.90

Ars Pharmaceuticals Inc Historical Returns

1 Month Return
-12.08 %
3 Month Return
-20.88 %
1 Year Return
-28.76 %
3 Year Return
-1.31 %
5 Year Return
0 %

Ars Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Ars Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$878.8M

EPS (TTM)

-1.5433

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-28.06

Industry PE ratio

0

PEG Ratio

0

EBITDA

-178.1M

Revenue (TTM)

84.3M

Profit Margin

-203.25%

Return On Equity TTM

-92.33%

Ars Pharmaceuticals Inc Stock Valuation

Track how Ars Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Ars Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (-95.35x)

June 30, 2023

Industry (0.00x)

March 19, 2026

Today (-28.06x)

March 19, 2026

Highest (24.31x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -28.06x

Ars Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ars Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$878.8MNA-28.06-203.25%
BUY$42.5B118.37%136.938.45%
BUY$117.5B108.96%30.2132.94%
NA$33.2BNA116.335.37%
BUY$80.2B57.09%18.3231.41%

Stock Returns calculator for Ars Pharmaceuticals Inc Stock including INR - Dollar returns

The Ars Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Ars Pharmaceuticals Inc investment value today

Current value as on today

₹78,483

Returns

₹21,517

(-21.52%)

Returns from Ars Pharmaceuticals Inc Stock

₹28,584 (-28.58%)

Dollar Returns*

₹7,067 (+7.07%)

Analyst Recommendation on Ars Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Ars Pharmaceuticals Inc. Average target price of $27

Ars Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Ars Pharmaceuticals Inc.

What analysts predicted

69.19%UPSIDE

Target Price

$27

Current Price

$8.32

Analyzed by

9 Analysts

Target

$27.00

Ars Pharmaceuticals Inc target price $27, a slight upside of 69.19% compared to current price of $8.32. According to 9 analysts rating.

Ars Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Ars Pharmaceuticals Inc Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Ars Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
0
2
86
7
15
32
28
Gross Profit
-3
-3
-5
0
1
82
3
10
24
24
Operating Income
-17
-10
-13
-15
-21
47
-37
-47
-53
-41
EBITDA
-17
-10
-13
-15
-21
47
-36
-44
-48
-41
Interest Expense
-
3
-
-
-
-
-
-
-
2
Depreciation
0
-6
-1
-1
-1
-1
-1
-1
0
-
Income Before Tax
-14
-7
-10
-12
-19
50
-33
-44
-51
-41
Income Tax Expense
0
3
0
-
-
0
-
-
-
0
Net Income
-14
-7
-10
-12
-19
49
-33
-44
-51
-41
Net Profit Margin
0.00%
23893.33%
0.00%
-2503.20%
-924.95%
57.67%
-425.69%
-285.57%
-157.38%
-147.13%

Ars Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
17
5
1
0
89
84
Gross Profit
3
5
1
0
68
63
Operating Income
0
-19
-35
-67
-3
-179
EBITDA
0
-19
-35
-67
-3
-178
Interest Expense
0
0
0
-
-
2
Depreciation
0
0
0
0
-7
-
Income Before Tax
-1
-20
-34
-54
8
-171
Income Tax Expense
0
0
0
0
0
0
Net Income
-1
-20
-34
-54
7
-171
Net Profit Margin
-5.97%
-367.65%
-2635.41%
-181216.67%
8.97%
-203.25%

Ars Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-7
-10
-12
-19
49
-33
-44
-51
-41
Operating Cash Flow
-17
-6
-7
-14
42
-40
-39
-47
-43
Investing Cash Flow
26
-8
-12
16
-101
29
48
-44
24
Financing Cash Flow
1
0
0
0
70
0
2
100
1
Change in Cash
10
-14
-19
3
11
-10
11
8
-18

Ars Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-1
-20
-34
-54
7
-171
Operating Cash Flow
-18
9
-17
-40
-59
13
-170
Investing Cash Flow
0
0
0
0
-87
-106
56
Financing Cash Flow
8
5
53
190
6
72
104
Change in Cash
-10
14
35
150
-139
-20
-9

Global Institutional Holdings in Ars Pharmaceuticals Inc

Funds
Holdings
Millennium Management LLC
3.19%
State Street Corp
2.92%
Citadel Advisors Llc
1.6%
Franklin Resources Inc
2.42%
Geode Capital Management, LLC
1.56%

Insights on Ars Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SPRY stock has moved up by 0.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -51.15M → -41.32M (in $), with an average increase of 23.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.2% return, outperforming this stock by 53.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 69.7% return, outperforming this stock by 71.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 32.50M → 28.08M (in $), with an average decrease of 13.6% per quarter

About Ars Pharmaceuticals Inc

silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.
OrganisationArs Pharmaceuticals Inc
Headquarters11682 El Camino Real, San Diego, CA, United States, 92130
IndustryHealthcare
CEOMr. Richard E. Lowenthal M.B.A., M.S., MSMSEL
E-voting on sharesClick here to vote

Key Management of Ars Pharmaceuticals Inc

Name

Title

Dr. Sarina Tanimoto M.B.A., M.D.

Co-Founder & Chief Medical Officer

Ms. Kathleen D. Scott CPA

Chief Financial Officer

Ms. Lynda Harris

Vice President of Human Resources

Mr. Justin Chakma

Chief Business Officer

Mr. Daniel Relovsky

Senior Vice President of Marketing

Mr. Eric Karas

Chief Commercial Officer

Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL

Co-Founder, President, CEO & Director

Mr. Brian T. Dorsey M.S.

Chief Operating Officer

Dr. Robert Bell Ph.D.

Co-Founder & Chief Science Officer

Mr. Alexander A. Fitzpatrick Esq.

Chief Legal Officer & Secretary

FAQs

What is Ars Pharmaceuticals Inc share price today?

Ars Pharmaceuticals Inc share price today is $8.32 as on at the close of the market. Ars Pharmaceuticals Inc share today touched a day high of $8.93 and a low of $8.32.

What is the 52 week high and 52 week low for Ars Pharmaceuticals Inc share?

Ars Pharmaceuticals Inc share touched a 52 week high of $18.9 on and a 52 week low of $6.66 on . Ars Pharmaceuticals Inc stock price today i.e. is closed at $8.32,which is 55.98% down from its 52 week high and 24.92% up from its 52 week low.

What is Ars Pharmaceuticals Inc's market capitalisation today?

Ars Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Ars Pharmaceuticals Inc Stock (SPRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ars Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ars Pharmaceuticals Inc Shares that will get you 0.1803 shares as per Ars Pharmaceuticals Inc share price of $8.32 per share as on March 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ars Pharmaceuticals Inc Stock (SPRY) from India?

Indian investors can start investing in Ars Pharmaceuticals Inc (SPRY) shares with as little as ₹92.634 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.34 in Ars Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ars Pharmaceuticals Inc share’s latest price of $8.32 as on March 19, 2026 at 1:29 am IST, you will get 1.2019 shares of Ars Pharmaceuticals Inc. Learn more about fractional shares .